Nature Podcast |
Featured
-
-
News & Views |
Targeting RNA opens therapeutic avenues for Timothy syndrome
A therapeutic strategy that alters gene expression in a rare and severe neurodevelopmental condition has been tested in stem-cell-based models of the disease, and has been shown to correct genetic and cellular defects.
- Silvia Velasco
-
Article |
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
VVD-133214, a clinical-stage, covalent allosteric inhibitor of the helicase WRN, was well tolerated in mice and led to robust tumour regression in multiple microsatellite-instability-high colorectal cancer cell lines and patient-derived xenograft models.
- Kristen A. Baltgalvis
- , Kelsey N. Lamb
- & Todd M. Kinsella
-
Editorial |
Any plan to make smoking obsolete is the right step
The United Kingdom is correct to attempt to end the single largest preventable cause of illness and death, as was New Zealand before its government changed its mind.
-
Spotlight |
Deadly diseases and inflatable suits: how I found my niche in virology research
Virologist Hulda Jónsdóttir studies some of the world’s most pathogenic viruses at the Spiez Laboratory in Switzerland.
- Nikki Forrester
-
News Feature |
Obesity drugs aren’t always forever. What happens when you quit?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
- McKenzie Prillaman
-
News Feature |
The rise of eco-anxiety: scientists wake up to the mental-health toll of climate change
Researchers want to unpick how climate change affects mental health around the world — from lives that are disrupted by catastrophic weather to people who are anxious about the future.
- Helen Pearson
-
Research Briefing |
Genetic risk variants lead to type 2 diabetes development through different pathways
The largest genome-wide association study for type 2 diabetes so far, which included several ancestry groups, led to the identification of eight clusters of genetic risk variants. The clusters capture different biological pathways that contribute to the disease, and some clusters are associated with vascular complications.
-
Nature Podcast |
The ‘ghost roads’ driving tropical deforestation
Researchers find that a huge number of roads that don’t appear on official maps, and the protein that could determine whether someone is left-handed.
- Nick Petrić Howe
- & Benjamin Thompson
-
Article |
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids
Glucocorticoids reprogram the mitochondrial metabolism of macrophages, resulting in increased and sustained production of the anti-inflammatory metabolite itaconate and, as a consequence, inhibition of the inflammatory response.
- Jean-Philippe Auger
- , Max Zimmermann
- & Gerhard Krönke
-
Correspondence |
Use fines from EU social-media act to fund research on adolescent mental health
- Christian Montag
- & Benjamin Becker
-
Technology Feature |
‘Without these tools, I’d be lost’: how generative AI aids in accessibility
A rush to place barriers around the use of artificial intelligence in academia could disproportionately affect those who stand to benefit most.
- Amanda Heidt
-
News |
Diabetes drug slows development of Parkinson’s disease
The drug, which is in the same family as blockbuster weight-loss drugs such as Wegovy, slowed development of symptoms by a small but statistically significant amount.
- David Adam
-
News Feature |
Why loneliness is bad for your health
A lack of social interaction is linked to a higher risk of cardiovascular disease, dementia and more. Researchers are unpicking how the brain mediates these effects.
- Saima May Sidik
-
Article |
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
Interim data from a clinical trial of mRNA-3927—an mRNA therapeutic for propionic acidaemia—provide early indications of the safety and efficacy of the treatment, and suggest that this approach might be applicable to other rare diseases.
- Dwight Koeberl
- , Andreas Schulze
- & Stephanie Grunewald
-
Article
| Open Access
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
The POLG1 mutation p.W748S, which is associated with mitochondrial recessive ataxia syndrome, dampens innate immune responses by compromising mtDNA replisome stability, and this explains why a viral infection can trigger the development of the disease and contribute to its variable clinical manifestation.
- Yilin Kang
- , Jussi Hepojoki
- & Anu Suomalainen
-
News |
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.
- Max Kozlov
-
Research Highlight |
Green space near home has an antidepressant effect
People who had the most vegetation near their residences were the least likely to report depression and anxiety.
-
Book Review |
The great rewiring: is social media really behind an epidemic of teenage mental illness?
The evidence is equivocal on whether screen time is to blame for rising levels of teen depression and anxiety — and rising hysteria could distract us from tackling the real causes.
- Candice L. Odgers
-
Outlook |
The future of at-home molecular testing
The COVID-19 pandemic showed what was possible for gene-based diagnostics. Now comes the true test – economics.
- Elie Dolgin
-
News |
Google AI could soon use a person’s cough to diagnose disease
Machine-learning system trained on millions of human audio clips shows promise for detecting COVID-19 and tuberculosis.
- Mariana Lenharo
-
News |
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.
- Smriti Mallapaty
-
Nature Podcast |
AI hears hidden X factor in zebra finch love songs
Machine learning detects song differences too subtle for humans to hear, and physicists harness the computing power of the strange skyrmion.
- Nick Petrić Howe
- & Benjamin Thompson
-
News Explainer |
Ketamine is in the spotlight thanks to Elon Musk — but is it the right treatment for depression?
The entrepreneur endorses the drug, but researchers caution that it’s not to be taken lightly.
- David Adam
-
Article
| Open Access
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
Poly(ADP-ribose) polymerase 1 (PARP1) functions together with TIMELESS and TIPIN to protect the replisome in early S phase from transcription–replication conflicts, and inhibiting PARP1 enzymatic activity may suffice for treatment efficacy in homologous recombination-deficient settings.
- Michalis Petropoulos
- , Angeliki Karamichali
- & Thanos D. Halazonetis
-
-
News |
Bird-flu threat disrupts Antarctic penguin studies
Projects have been cancelled in an effort to curb the virus’s spread.
- Carissa Wong
-
News |
First US drug approved for a liver disease surging around the world
A therapy called resmetirom improves hallmarks of an obesity-linked condition that can lead to liver failure.
- Heidi Ledford
-
Outlook |
Fungal diseases are spreading undetected
Low- and middle-income countries are grappling with widespread shortages of diagnostic tests for infections that kill millions.
- Charles Schmidt
-
Nature Index |
Researchers call for a major rethink of how Alzheimer’s treatments are evaluated
An approach that aims to quantify how long a drug can delay or halt the progression of disease is gathering steam.
- Esther Landhuis
-
News |
Ancient malaria genome from Roman skeleton hints at disease’s history
Genetic information from ancient remains is helping to reveal how malaria has moved and evolved alongside people.
- Tosin Thompson
-
Research Briefing |
Dysregulated cellular stress management becomes a source of stress
Stress responses protect cells from harmful conditions, but once the stress has resolved, these responses must be actively turned off to avoid cell damage that might lead to the development of neurodegenerative disease.
-
News |
Blockbuster obesity drug leads to better health in people with HIV
Semaglutide reduces weight and fat accumulation associated with the antiretroviral regimen that keeps HIV at bay.
- Mariana Lenharo
-
News Explainer |
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
Therapy built on tumour-infiltrating lymphocytes is now being prepared for at least 20 people in the United States with advanced melanoma.
- Sara Reardon
-
Outlook |
Could the gut give rise to alcohol addiction?
Microorganisms in the gut might make a person more vulnerable to substance-use disorders.
- Tammy Worth
-
Nature Podcast |
These tiny fish combine electric pulses to probe the environment
Elephantnose fish share electric pulses to extend their senses, and the bumblebees that show a uniquely human trait.
- Nick Petrić Howe
- & Benjamin Thompson
-
Correspondence |
Personalized cancer care can’t rely on molecular testing alone
- James Larkin
- , Chloe Beland
- & Alexander R. Lyon
-
Correspondence |
Forget lung, breast or prostate cancer? Why we shouldn’t abandon tumour names yet
- Albrecht Stenzinger
- & Frederick Klauschen
-
News |
Meningitis could be behind ‘mystery illness’ reports in Nigeria
The WHO confirms three meningitis deaths, which it says might have triggered rumours of an outbreak of an unknown disease.
- Sarah Wild
-
News |
Organoids grown from amniotic fluid could shed light on rare diseases
Organ-like groups of cells can be grown from amniotic fluid samples and offer hope for studying congenital conditions.
- Lilly Tozer
-
News |
Brazil’s record dengue surge: why a vaccine campaign is unlikely to stop it
A vaccine shortage and persistent sanitation problems threaten the success of the world’s first public vaccination campaign against dengue virus.
- Mariana Lenharo
-
News & Views |
Non-neuronal brain cells modulate behaviour
A single gene in astrocytes can constrain repetitive behaviours, indicating that these cells are regulators of behavioural disruption in conditions such as Huntington’s disease and obsessive–compulsive disorder.
- Anna Kruyer
-
Spotlight |
Stealthy stem cells to treat disease
Gene-editing strategies that allow stem cells to evade the immune system offer hope for universal cell-replacement therapies.
- Elie Dolgin
-
News & Views |
Synchronized neuronal activity drives waste fluid flow
Active neurons can stimulate the clearance of their own metabolic waste by driving changes to ion gradients in the surrounding fluid and by promoting the pulsation of nearby blood vessels.
- Lauren Hablitz
- & Maiken Nedergaard
-
News Feature |
Can non-profits beat antibiotic resistance and soaring drug costs?
Effective, affordable antimicrobial drugs aren’t moneymakers, despite being desperately needed. Can non-profit organizations pick up the slack?
- Maryn McKenna
-
News |
‘Epigenetic’ editing cuts cholesterol in mice
Changes to chemical tags on DNA in mice dial down the activity of a gene without cuts to the genome.
- Heidi Ledford
-
Article
| Open Access
Incomplete transcripts dominate the Mycobacterium tuberculosis transcriptome
A study reveals that most transcripts in Mycobacterium tuberculosis are incomplete, likely because of the tendency of the transcription machinery in this species to pause on genomic DNA.
- Xiangwu Ju
- , Shuqi Li
- & Shixin Liu
-
Article
| Open Access
Crym-positive striatal astrocytes gate perseverative behaviour
In mice, a population of astrocytes in the central striatum, characterized by expression of μ-crystallin, has a role in perseveration phenotypes that are often associated with human neuropsychiatric disorders.
- Matthias Ollivier
- , Joselyn S. Soto
- & Baljit S. Khakh
-
Correspondence |
Speed up relief for long COVID through grassroots clinical trials
- Marc Jamoulle
- , Elena Louazon
- & Johan Van Weyenbergh
-
Nature Podcast |
Audio long read: Chimpanzees are dying from our colds — these scientists are trying to save them
Endangered apes are increasingly being put at risk by human diseases.
- Rachel Nuwer
- & Benjamin Thompson
Audio long read: Why loneliness is bad for your healthBrowse broader subjects
Browse narrower subjects
- Cancer
- Cardiovascular diseases
- Dental diseases
- Endocrine system and metabolic diseases
- Eye diseases
- Gastrointestinal diseases
- Haematological diseases
- Immunological disorders
- Infectious diseases
- Kidney diseases
- Metabolic disorders
- Neurological disorders
- Nutrition disorders
- Oral diseases
- Psychiatric disorders
- Reproductive disorders
- Respiratory tract diseases
- Rheumatic diseases
- Skin diseases
- Trauma
- Urogenital diseases
